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ABSTRACT
GAP JUNCTION COMMUNICATION
IN MEMORY RETRIEVAL AND EXTINCTION OF COCAINE SEEKING
by
Michael K. Fitzgerald

The University of Wisconsin-Milwaukee, 2016
Under the Supervision of Devin Mueller

Blocking drug-associated memory retrieval or enhancing extinction of drug-seeking behavior are
two strategies that could limit relapse in drug addicts. The loci of retrieval and extinction
memory processes include the prelimbic medial prefrontal cortex and the infralimbic medial
prefrontal cortex, respectively. The neurochemical and synaptic mechanisms underlying drugrelated behavior have received considerable attention, but extrasynaptic mechanisms are
relatively unexplored. One form of cellular communication, gap junction communication, may
play a role in drug-related learning and memory. Gap junction communication between
neurons and astrocytes provide a cytoplasmic continuity between connected cells and both
neuronal and astrocytic gap junction communication have been demonstrated to be involved
with development and maintenance of the CNS, and also aversive and appetitive paradigms of
learning. However, in retrieval or extinction of drug-seeking behavior, the role of gap junction
communication is unknown. Here I describe a series of experiments that investigate astrocytic
and neuronal gap junction communication in the retrieval and extinction of a cocaine
conditioned place preference using microinfusions and confocal imaging.
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Introduction
Drug-associated cues can trigger craving and relapse in drug addicts. Preventing retrieval
of cue-associated memories or reducing cue reactivity through extinction has been
demonstrated to reduce drug-seeking behavior in various drug-seeking models (LaLumiere et
al., 2010; Groblewski et al., 2012). Retrieval of a cocaine-associated memory is dependent on
activation of the prelimbic medial prefrontal cortex (PL-mPFC; Otis et al., 2013) whereas
extinction of cocaine seeking is consolidated in the infralimbic medial prefrontal cortex (ILmPFC; Otis et al., 2014). Although the neurochemical and synaptic mechanisms underlying
drug-related behavior have been investigated intensively, little is known regarding the
contribution of neural or astrocytic gap junction communication in the PL-mPFC and IL-mPFC.
Both neurons and astrocytes express gap junctions, which are specialized membrane
structures built of connexin channels that allow cytoplasmic continuity between connected cells
(Connors & Long, 2004; Pannasch & Rouach, 2013). Neuronal or astrocytic gap junction
communication can alter neuronal activity and plasticity (Palacios-Prado et al., 2014; Pannasch
et al., 2011). However, how gap junction communication blockade affects memory retrieval and
extinction of drug-seeking behavior is not known. Here I describe how gap junction
communication in the brain plays integral roles in neuronal and astrocytic development,
maintenance, and ongoing plasticity. Next I describe a series of experiments that were
performed to investigate gap junction communication in the retrieval and extinction of drugseeking behavior using the conditioned place preference (CPP) paradigm and confocal
microscopy.
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The conditioned place preference procedure
The mechanisms of drug-associated memory retrieval can be investigated using the CPP
paradigm. This paradigm is an animal model of drug seeking in which rats learn to associate
environmental stimuli with cocaine. During training, rats are given experimenter-delivered
cocaine or saline followed by exposure to one or another of two chambers. Following training,
rats are given full access to both the cocaine- and saline-paired chambers, along with a neutral
center chamber. Rats spend more time in the previously cocaine-paired chamber during this
trial, thus expressing a cocaine-induced CPP (Mueller & Stewart, 2000). When a CPP is
expressed, investigators can be certain that the rats acquired, consolidated, and retrieved this
cocaine-associated memory. Additionally, rats that express a CPP on additional test trials
demonstrate that they are subsequently able to retrieve the cocaine-associated memory.

The PL-mPFC and drug-associated memory retrieval
Recall or retrieval of memory refers to the subsequent re-accessing and behavioral
expression of previously encoded and stored information. Studies have demonstrated that
memory expression can be enhanced by pre-test treatment of nicotine (Faiman et al., 1992),
cocaine (Rodriguez et al., 1993), or amphetamine (Sara & Deweer, 1982). These drugs are
nonspecific, but all of them enhance noradrenergic signaling. Stimulation of the noradrenergic
system can influence memory task performance. For example, blockade of α2-adrenergic
autoreceptors, which normally prevent norepinephrine from being released, leads to an
increase in rat performance in maze navigation after the task had been forgotten (Sara, 1985;
Sara & Devauges, 1989). Moreover, stimulation of the locus coeruleus (LC), a major nucleus of
2

noradrenergic cell bodies (Dahlstroem & Fuxe, 1964), also enhances memory expression after
forgetting. This enhancement is prevented by the β-adrenergic receptor (β-AR) antagonist
propranolol (Devauges & Sara, 1991). Work from our lab has demonstrated that systemic β-AR
blockade can prevent retrieval of a cocaine CPP (Otis & Mueller, 2011). Additionally, β-AR
blockade prevents an increase in neuronal excitability in PL-mPFC neurons (Otis et al., 2013).
Investigation of the loci of retrieval of a cocaine CPP revealed a role for the PL-mPFC. The PLmPFC has previously shown to be necessary for expression of memories and decision making
(Corcoran and Quirk, 2007; Kim et al., 2013; Euston et al., 2012). Additionally, glutamatergic
driven neuronal activity within PL-mPFC has been shown to be necessary for expression of
innate (Freitas et al., 2013) and learned (Davies et al., 2013; Gilmartin et al., 2013) behaviors.
Infusions of the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or the
GluN2B-selective antagonist Ro 25-6981 into PL-mPFC reduced span capacity in rats, a measure
of working memory. Furthermore, CNQX or Ro 25-6981 also induced a failure to retrieve the
correct choice in an appetitive choice task for rats (Davies et al., 2013). Based on these studies
demonstrating the necessity of PL-mPFC in memory retrieval across tasks, our lab examined the
effects of microinfusions of non-selective β-AR antagonists into the PL-mPFC in retrieval of a
cocaine CPP (Otis et al., 2013). We found that blockade of β-ARs in PL-mPFC impaired retrieval
of the cocaine CPP. Thus, the PL-mPFC is necessary for cocaine-associated memory retrieval
necessary for drug-seeking behavior.
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The IL-mPFC and extinction of drug seeking
Extinction is the reduction in drug seeking across trials when the drug-predictive stimuli
no longer predict the delivery of a drug reward. Importantly, extinction is an active learning
process (Sutton et al., 2003; Knackstedt et al., 2010), is context specific (Bouton et al., 2000,
2004; Wells et al., 2011) and does not erase the original drug-related memory (Tobena et al,
1993; Di Ciano & Everitt, 2004). Rather, extinction learning results in the formation of an
inhibitory memory that suppresses drug seeking. Extinction of ethanol seeking (Groblewski et
al., 2012), morphine seeking (He et al., 2011), and cocaine seeking (Otis et al., 2014) is
consolidated in the IL-mPFC. Retrieval of the extinction memory is dependent on the IL-mPFC,
as lesioning of this structure does not disrupt acquisition of extinction within a session, but does
impair retrieval of the extinction memory when tested in later trials (Quirk et al., 2000). For
example, Do-Monte et al. (2015) optogenetically activated or silenced the IL-mPFC during
extinction training and found that activation reduced the expression of freezing and facilitated
extinction learning during both the acquisition and retrieval test days. Furthermore, silencing
the IL-mPFC during extinction training yielded similar results to Quirk et al (2000) where ILmPFC silencing did not disrupt acquisition of extinction within the initial session, but did impair
retrieval of the extinction memory in later trials.
So far, I have described how the PL-mPFC and IL-mPFC are involved in the retrieval and
extinction of drug seeking. Next, I will describe gap junctions and how they have been
demonstrated to be involved in drug-seeking behavior. I will begin with a background of the
function of gap junctions to show their involvement in development and in different forms of
plasticity.
4

Gap junctions
Gap junctions were first detected by electron microscopy in the brains of primates and
rats. For example, the CA1 and CA3 regions of the hippocampus (Kosaka, 1983), the
sensorimotor cortex (Sloper and Powell, 1978), and the brainstem and cerebellum all contain
gap junctions (Sotelo and Korn, 1978). Gap junctions allow intercellular electro- and metaboliccoupling between adjoining cells and are found in organs and tissues that rely on fast
intercellular signaling, transfer and communication, including the brain, heart, skin, and inner
ear. Gap junctions have critical roles in brain development and maturation, and contribute to
neural precursor cell proliferation, as well as cell migration and differentiation (Bruzzone and
Dermietzel, 2006).
Gap junctions are intercellular channels with a diameter of 1.2 nm, and form an aqueous
pore that penetrates the lipid bilayer of two connected cells. These channels are formed by two
hemichannels or connexons, with a connexon contributed by each cell. Connexons are
composed of six protein subunits called connexins (Kumar and Gilula, 1996). Gap junctions
permit the bidirectional diffusion of nutrients, ions, metabolites, and second messengers,
including potassium, calcium, cyclic adenosine monophosphate (cAMP), inositol 1,4,5triphosphate (IP3), cyclic monophosphate, glucose, and other small molecules of about 1000 Da
or less (Dobrowolski and Willecke, 2009; Zoidl and Dermietzel, 2010).
Connexin genes and their corresponding proteins are named according to the molecular
weight of different connexin proteins (e.g., Cx43 has a mass of 43 kilodaltons). The molecular
topography of connexin proteins include four alpha-helical transmembrane domains,
intracellular N- and C- termini, two extracellular loops, and a cytoplasmic loop. There are two to
5

three cysteine residues located in the extracellular loops, which are needed for the proper
alignment of two connexons to form a continuous gap junction channel (Yeager, 1998). The
cytoplasmic C-terminus carries several serine, threonine, and tyrosine residues, which serve as
targets for a number of protein kinases and phosphatases for posttranslational modifications
(Solan and Lampe, 2005).
To date more than 20 different connexin genes have been identified and are expressed
in many different cells and tissues in mammals (McCracken and Roberts, 2006). I will focus on
two, Cx36 and Cx43, as these are the two brain connexins expressed in neurons and astrocytes,
respectively.

Neuronal gap junction communication
The combination of in situ hybridization and immunocytochemistry for the neuronspecific DNA-binding protein NeuN demonstrated that, in rat and human cortices,
approximately 10% of neurons express Cx36 (Belluardo et al., 1999, 2000; Condorelli et al.,
2000). Co-localizing Cx36 mRNA with parvalbumin, a GABAergic interneuron marker, confirmed
that GABAergic inhibitory interneurons express Cx36 (Belluardo et al., 2000). Furthermore,
simultaneous recordings revealed that cortical GABAergic interneurons, and not pyramidal cells,
are interconnected via electrical synapses (Galarreta and Hestrin, 1999; Gibson et al., 1999).
The gap junctions of inhibitory neurons were shown by ultrastructural studies to be located
between dendrites, or between dendrites and somata (Szabadics et al., 2001; Tamas et al.,
2000). Cx36 has been thoroughly investigated and has been shown to be selectively expressed
in neurons and to participate in neuronal gap junctions found in the hippocampus, neocortex,
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basal ganglia, cerebellum, inferior olive, suprachiasmatic nucleus, pedunculopontine nucleus,
and the thalamic reticular nucleus (Garcia-Rill et al., 2007; Landisman et al., 2002; McCracken
and Roberts, 2006; Sohl et al., 2005, 2006).
The generation of mice with disruption of the Cx36 gene (Gueldenagel et al., 2001; De
Zeeuw et al., 2003) provided insight and confirmation of the inclusion of Cx36 in the formation
of gap junctions between inhibitory neurons. In the Cx36-deficient mice, a gap junction-like
structure was still observed, but the interneuronal space was reduced to 9 nm. Dye-coupling
experiments demonstrated a failure of direct electrical coupling in the Cx36 knockout mice (De
Zeeuw et al., 2003).
The availability of Cx36 knockout mice has also allowed for the study of the role of gap
junctions in learning and memory (Frisch et al., 2005). Allen et al (2011) demonstrated that
Cx36 knockout mice displayed impaired spatial memory in the open field and in zigzag maze
running. Additionally, slower hippocampal theta oscillations were observed in the Cx36
knockout mice. The authors theorized that Cx36-coupled interneurons play a functional role in
spatial coding and cognition (Allen et al., 2011). A possible explanation for the failure of these
Cx36 knockout mice to learn could be deficiencies in the mechanisms of long-term potentiation
(LTP). The induction of LTP, which is considered a cellular model of learning and memory, is
impaired in Cx36-deficient animals in the visual cortex (Postma et al., 2011) and the
hippocampus (Wang and Belousov, 2011). Interestingly, Wang and Belousov performed a
western blot analysis of NMDA receptor subunits and found a higher GluN2A/GluN2B ratio in
Cx36 knockout mice and theorized that there is shift in the threshold for LTP induction in
knockout animals. Postma et al (2011), however, found equal levels of GluN2A and GluN2B
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mRNAs in Cx36 knockout animals and controls. One could argue that deletion of Cx36 would
have an impact on an animal’s healthy development and subsequent normal function.
Although Cx36 is expressed early in the development of the embryonic brain (Gulisano et al.,
2000), no developmental or morphological abnormalities were observed by Sohl et al (2004) in
the neocortex of Cx36-deficient mice. However, it has also been reported that knockdown of
Cx36 significantly reduces the number of differentiated neurons and increases the number of
differentiated astrocytes (Hartfield et al., 2011). Thus, Cx36 may regulate early neurogenesis
during development.
In addition to being able to genetically alter Cx36, pharmaceutical treatment can block
to block Cx36-containing gap junctions (Juszczak & Swiergiel, 2009). One compound is the
antimalarial drug mefloquine (Cruikshank et al., 2004). Mefloquine has been utilized for local
microinfusions and has shown to be effective at impairing context-dependent fear learning
when infused into the dorsal hippocampus in rats prior to or following training (Bissiere et al.,
2011). Furthermore, unilateral infusion of mefloquine into the ventral hippocampus combined
with a contralateral infusion into the mPFC decreases anxiety-like behavior on the elevated plus
maze in mice (Schoenfeld et al., 2014). However, it should be noted that the dose of
mefloquine used in these experiments (100 mM) can block astrocyte Cx43 junctions as well
(Cruikshank et al., 2004).
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Astrocytic gap junction communication
In the adult brain, Cx43 is the main connexin spanning the astrocytic gap junction
network (Yamamoto et al., 1992). The term astrocyte or “star-like cell” was first used by
Michael von Lenhossek in 1891 (Lenhossek, 1891). Astrocytes can have a star-like appearance,
and express glial fibrillary acidic protein (GFAP), a protein used to identify astrocytes (Tong et al.,
2014). The list of astrocyte functions is extensive, and is generally focused on maintaining CNS
homeostasis. For example, astrocytes form and maintain the blood brain barrier (Abbott, 2005),
and deletion of Cx43 can weaken the integrity of the blood brain barrier (Ezan et al., 2012).
Astrocytes have also been shown to be involved in neurogenesis, both pre- and post-natally
(Alvarez-Buylla et al., 2001). Astrocytes also contribute to morphological homeostasis by
defining the migration of neural cells during development (Nedergaard et al., 2003), and also
help regulate synaptogenesis and synaptic pruning to shape the microarchitectural framework
of gray matter (Pfrieger, 2009). Astrocytes also help regulate molecular homeostasis by
regulating the concentrations of ions, neurostransmitters, and neurohormones in the CNS
(Danbolt, 2001; Newman, 1995) and also detect systemic fluctuations of carbon dioxide, pH,
sodium, and potassium (Gourine and Kasparov, 2011; Gourine et al., 2010; Huckstepp et al.,
2010; Shimizu et al., 2007). Astrocytes are also involved with metabolic homeostasis by
accumulating energy substrates and supplying neurons with lactate (Magistretti, 2006).
Another role of astrocytes is their defensive protection and structural maintenance of neural
tissue following trauma or the introduction of pathogens (Pekny and Nilsson, 2005).
From the aforementioned functions of astrocytes, it is easy to see how involved
astrocytes are in supporting the cellular and molecular components of neural activity. However,
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the last fifteen years has seen an explosion of research showing how astrocytes are not only
directly involved with supporting neural network integrity, but also are directly involved in
cellular and molecular mechanisms through interactions with neurons to build higher cognitive
functioning in the brain. An integral part of this ability is gap junction communication of
calcium between astrocytes. In 1992, Steven Finkbeiner loaded astrocytes with a calciumattaching dye and was able to visualize diffusing calcium moving from one cell to the next in a
curvilinear pattern (Finkbeiner, 1992). Astrocytes each contain an endoplasmic reticulum (ER),
an internal complex that stores calcium concentrations as high as 0.2-1 mM, whereas the
calcium concentration inside the cytoplasm at baseline is set at about 50-100 nM (Alonso et al.,
1999; Mogami et al., 1998; Solovyova and Verkhratsky, 2002). ERs each contain ryanodine
receptors (RyRs) and inositol 1,4,5-triphosphate (IP3)-gated receptors. Activation of either RyR
or IP3 receptors triggers an ER to release its calcium. RyRs can become activated by calcium
whereas IP3 receptors can be activated by either calcium or by the second messenger IP3 (IP3 is
produced by activation of metabotropic receptors linked with phospholipase C) (Bezprozvanny,
2005). Hence, astrocytes are capable of calcium-induced calcium release (Verkhratsky and
Kettenmann, 1996). Finkbeiner (1992) demonstrated that this calcium-induced calcium release
is possible following glutamatergic activation of metabotropic G-protein coupled receptors that
are linked to phospholipase C and the second messenger IP3. Roughly 230 gap junctions connect
a pair of astrocytes and 50-100 neighboring astrocytes can be influenced by a single calcium
wave (Innocenti et al., 2000). Probably the most intriguing aspect of calcium sharing between
astrocytes is the fact that astrocytes, like neurons, use calcium as a catalyst to release
transmitters into the extracellular space. In 1994, Parpura and colleagues discovered that
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astrocytes are capable of releasing glutamate into the extracellular space after a calcium wave
spreads between astrocytes (Parpura et al., 1994). Additionally, astrocytes release transmitters
in a calcium-dependent manner involving SNARE protein mediated fusion of vesicles with the
cell’s plasma membrane (Araque et al., 2000; Zhang et al., 2004). Furthermore, astrocytes have
vesicles located in close proximity to synapses that contain different neuroactive
molecules/transmitters like glutamate, d-serine, ATP, adenosine, GABA, tumor necrosis factor α,
and prostaglandins (Bezzi et al., 2004, Volterra & Bezzi, 2002).
The body of work by Finkbeiner and others during the 90’s has stimulated investigation
of the relationship between neurons and astrocytes in structures throughout the brain.
Pirttimaki and colleagues (2011) showed that neuronal corticothalamic glutamate release can
trigger astrocytic calcium waves, and astrocytes can subsequently release glutamate primarily
targeting NMDA receptors on neurons. Furthermore, Jourdain and colleagues (2007) studied
communication between astrocytes and neurons in the hippocampus in the dentate molecular
layer using a combination of patch-clamp electrophysiology and calcium imaging, and
demonstrated that glutamate release from astrocytes enhances synaptic strength within the
surrounding neurons. By measuring the flow of positively charged ions into the postsynaptic
neuron, they observed that when astrocytes were stimulated to release a calcium wave, there
was an increase in neuronal electrical activity as compared to the activity of neurons stimulated
independently of astrocyte stimulation (Jordain et al., 2007).
Astrocytes have also been implicated in LTP and long-term depression (LTD).
Henneberger and his colleagues (2010) investigated the role of astrocytes in LTP at Schaffer
collateral – CA1 pyramidal cell synapses. Henneberger and colleagues (2010) observed that
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holding and preventing elevations of internal calcium levels in astrocytes in the CA1 region
blocked LTP at excitatory synapses. Furthermore, they determined that performing a calcium
clamp on the astrocytes prevented astrocytes from releasing D-serine since LTP blockade could
be reversed by exogenous application of D-serine (Henneberger et al., 2010). Regarding LTD,
Chen’s group (2013) demonstrated that LTD is dependent on calcium elevation in astrocytes
leading to release of ATP that then acts on P2Y receptors on hippocampal neurons. Blocking
P2Y receptors or buffering astrocyte calcium at a low level prevented LTD (Chen et al., 2013).
So far, I have discussed how neuronal and astrocytic gap junction communication is
capable of altering neural activity and plasticity, and have provided some examples of how gap
junction communication is involved in non-addictive behavior. Next, I will focus on data that has
been collected relating gap junction communication to addictive behaviors.
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Gap junction communication in reward-seeking and addictive behaviors
A growing body of literature has emerged investigating gap junction communication in
relation to addictive behaviors. Here I describe gap junction involvement in drug-seeking
behavior within different brain regions during different time points of drug-seeking.
The ventral tegmental area (VTA) is the beginning of the mesolimbic pathway, which is
also known as the reward pathway (Kauer, 2004). The VTA projects to areas such as the nucleus
accumbens, prefrontal cortex, and amygdala, which interpret environmental stimuli and internal
states that can affect drug-seeking behavior (Cohen et al., 2012; Schultz, 2006). Gap junction
communication can alter behavior associated with activity in the mesolimbic pathway. For
example, Lassen and colleagues (2007) systemically injected either the non-selective gap
junction blocker quinidine or the Cx36-specific blocker mefloquine and found that general and
Cx36 blockade significantly increased the threshold within the VTA for responding to rewarding
self-stimulation. They theorized that VTA gap junction communication blockade reduces the
rewarding impact of self-stimulation. It is interesting to note that the animals were still able to
search out pleasure/rewarding stimuli, but required greater stimulation. Notably, this study
involved systemic administration, and the assessment of this data should be taken carefully
because all regions of the brain were accessed by gap junction antagonists.
A reduction of pleasure-seeking behavior by gap junction communication blockade also
occurred in an experimental design reminiscent of Olds and Milner (1954) performed by
Kokarovtseva and colleagues (2009), Kokarovtseva et al. trained rats to press a lever to receive
an electrical current in the hypothalamus. The hypothalamus, particularly the lateral region,
when stimulated causes pleasure and feelings of reward through glutamatergic projections to
13

the VTA. After training, the authors microinfused the non-selective gap junction blocker
carbenoxolone (CBX) into the nucleus accumbens to investigate drug-seeking behavior. Intraaccumbens CBX reduced lever-pressing activity. Infusions of tetrodotoxin (TTX) also produced a
similar decrease in lever-pressing behavior. Kokarovtseva et al. theorized that blocking gap
junctions reduces the level of neuronal excitability. Additionally, as a control, CBX or TTX were
infused into the motor cortex to examine the function of gap junctions in forelimb motor ability.
No effect was found, indicating that the effects of CBX and TTX were reward-specific.
The previous experiments demonstrated that blocking gap junction communication
following training can decrease drug-seeking behavior. In animals that have gone through a
prolonged withdrawal from a drug, an opposite effect is observed. Bull and colleagues (2014)
investigated gap junction communication in the nucleus accumbens of rats following three
weeks of withdrawal from ethanol. They demonstrated that after withdrawal, non-selective or
astrocytic gap junction blockade caused an increase in lever pressing in ethanol-experienced
rats compared to controls. Neuronal gap junction blockade had no effect on lever pressing.
Additionally, they demonstrated that selective Gαq-DREADDs activation of astrocytic
intracellular calcium in the nucleus accumbens, decreased lever pressing after three weeks of
abstinence. Therefore, astrocytic, but not neuronal, gap junction communication is necessary
for prevention of drug-seeking behavior following withdrawal. Astrocytic calcium gap junction
communication may be needed for decreasing drug-seeking behavior during periods of
withdrawal within the nucleus accumbens to counter dysregulation of glutamate exchange
between astrocytes and neurons (Kalivas 2009). During withdrawal, insertion of calciumpermeable AMPA receptors into the presynaptic membrane of nucleus accumbens neurons
14

occurs (Wolf & Tseng, 2012), as well as the addition of structural proteins such as actin and
myosin to form new synapses. These structural changes increase output from the nucleus
accumbens and strengthen the drive to drug-seek.
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Dissertation Goal and Aims
The PL-mPFC and IL-mPFC underlie drug-associated memory retrieval and extinction of
drug-seeking behavior, respectively. Above, I have described how blockade of activity within
these structures prevents the behavioral expression of drug seeking. Additionally, I have
described how blockade of gap junction communication prevents behavioral expression of both
addictive and non-addictive behaviors. Thus, gap junction communication plays an important
mechanistic role in memory processing.
Although gap junction blockade disrupts addictive memories, the specific neuronal or
astrocytic gap junction communication necessary for retrieval and extinction within the PLmPFC and IL-mPFC has remained unexplored. Therefore, the overall goal of this dissertation
was to investigate general, neuronal, or astrocytic gap junction communication in the retrieval
and extinction of a cocaine CPP. This was addressed in the following two aims.
Aim 1: Determine whether gap junction communication is a mechanism for memory retrieval
and extinction of a cocaine CPP. Here I evaluated the behavioral effect of blocking general,
neuronal, or astrocytic gap junction communications within PL-mPFC and IL-mPFC on retrieval
and extinction of a cocaine CPP. We hypothesized that general or astrocyte specific gap junction
blockade would prevent a net increase in available transmitter shared at the synapse thereby

Aim 2: Evaluate PL-mPFC astrocytic calcium levels following general, neuronal, or astrocytic
gap junction communication blockade. Next, using confocal microscopy I determined the
underlying effects of the gap junction blockers used in Aim 1 on calcium levels in PL-mPFC
astrocytes.
16

Methods
Subjects
Adult male Long-Evans rats weighing 275-300 grams were housed individually
in clear plastic cages with access to standard laboratory rat chow (Harlan Laboratories)
and water ad libitum unless otherwise noted. Rats were maintained on a 14 hour
light/10 hour dark cycle (lights on at 7am), and were weighed and handled daily. All
experimental protocols were approved by the Institutional Animal Care and Use
Committee at the University of Wisconsin-Milwaukee in accordance with National
Institutes of Health guidelines.

Methods: Aim 1
Aim 1 was completed to determine the behavioral effect of general, neuronal, or astrocytic gap
junction communication disruption within the PL-mPFC for retrieval (Aim 1a) and IL-mPFC for
extinction (Aim 1b) of a cocaine CPP.

Aim 1a: Retrieval of cocaine CPP
Cannula surgery
PL-mPFC cannula surgeries were performed to allow PL-mPFC gap junction blockade for
retrieval of a cocaine CPP. Rats were anesthetized with ketamine/xylazine (90 mg/kg, 10.5
mg/kg, i.p.). Following anesthetization, double-barrel guide cannula (26 gauge; Plastics One,
Roanoke, VA) were implanted within PL-mPFC (AP, +2.9; ML, ±0.6; DV, -2.9 mm relative to
bregma). Cannula were fixed into place with 3 stainless steel skull screws and grip cement.
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Following surgery, rats were treated with an antibiotic (penicillin g procaine, 75,000 units in 0.25
ml, s.c.) and an analgesic (carprofen, 5.0 mg in 0.1 ml, s.c.). Rats were given a minimum of 7
days for recovery following surgeries, during which behavioral experiments were not
conducted. Stylets remained within the guide cannula following surgery to maintain patency
until microinfusions were performed.

Drugs and microinfusions
For conditioning, cocaine HCl (National Institute on Drug Abuse) was dissolved in sterile
0.9% saline at a concentration of 10 mg/mL, and administered i.p. at a dose of 10 mg/kg. PLmPFC infusions of vehicle (0.9% saline), the non-selective gap junction blocker carbenoxolone
(CBX; 50 mM, Tocris), the neuron specific gap junction blocker quinine (100 uM, Tocris), or the
astrocyte specific gap junction blocker IRL-1620 (0.1 uM, Tocris) were administered at 0.3 μl /
side over a 2 minute time period. All drugs were dissolved into sterile 0.9% saline. Microinfusion
injectors were then left in place for a minimum of 1 minute following microinfusions. Doses of
each gap junction blocker were based on previous studies (Blomstrand et al., 1999; Cruikshank
et al., 2004; Sun et al., 2012).

Place conditioning
Place conditioning and testing was conducted in a 3-chamber apparatus that
contained 2 distinguishable conditioning chambers (13” x 9” x 11.5”) which were separated
by a smaller center chamber (6” x 7” x 11.5”). One of the conditioning chambers had
wire mesh flooring with white walls, whereas the other conditioning chamber had gold- grated
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flooring with a black wall. The smaller center chamber had aluminum sheeting as flooring and
all white walls. Each of the larger chambers contained two infrared photobeams separated by
3”. If the beam furthest from the center chamber was broken, then the rat was determined to
be in the larger chamber. If only the beam closest to the center chamber was broken, then the
rat was determined to be in the center chamber. In addition, the total numbers of photobeam
breaks were recorded during microinfusion trials to quantify locomotor activity.
Baseline preferences were assessed by placing the rats into the center chamber with
free access to the entire CPP apparatus for 15 minutes. We previously demonstrated that rats
spend equivalent time within the larger chambers before conditioning (Otis and Mueller, 2011).
Thus, following baseline testing, rats were conditioned to associate one chamber, but not
another, with cocaine in a counterbalanced fashion over 8 days. Injections of saline or cocaine
were administered immediately before each 20 minute conditioning session, during which rats
were confined to the appropriate chamber. Following conditioning, microinfusion adaptation
was performed by lowering injector tips 1.0 mm past the guide cannula for 2 minutes. The
following day, the same procedure took place, except that saline was infused (0.3 μl / side / 2
min). These procedures allowed for the rats to adapt to mechanical stimulation and changes in
cranial pressure that occured during microinfusions.

Experimental manipulations
For retrieval testing, rats were separated into one of four groups. The vehicle group
contained control animals that received vehicle (0.9% saline). Group CBX received the nonselective gap junction blocker carbenoxolone. Group IRL-1620 received the astrocyte-specific
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gap junction blocker IRL-1620. Group Quinine received the neuron-specific gap junction blocker
quinine. Following conditioning and 10 minutes prior to the first CPP test, all groups received
their respective drug manipulation. During the CPP test, all animals had full access to all
chambers for 15 minutes (Otis et al., 2013). Additional drug-free daily CPP tests followed to
determine if gap-junction blockade had any persistent effect on memory retrieval. Animals
continued to receive daily drug-free CPP tests until they reached extinction criterion of two
consecutive days of no significant CPP.

Alternative Strategies Implemented: Aim 1
As described in the Alternative Strategies portion of the original proposal, different
possibilities were described as to why the experiments proposed in Aim 1a would result in
trends, but not significant differences in retrieval disruption. Significant differences were
observed within the original experiments proposed in Aim 1a, however additional retrieval
experiments were performed following completion of the original experiments proposed in Aim
1a.
Additional Experiment 1: Restoration of GABAergic tone following neuronal gap junction
blockade via quinine rescues normal CPP behavior
Cannula surgery, drugs and microinfusions, place conditioning, and behavioral testing were all
performed as described above with the exception of quinine (100 uM) and the potent
GABAA receptor agonist muscimol (0.0001 uM, dose determined by Sajdyk et al., 2008 ) being
co-infused prior to the first test trial.
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Additional Experiment 2: Preventing retrieval of CPP via blockade of astrocyte gap junctions
with IRL-1620 in addition to blockade of astrocyte hemichannels with Gap19
Gap junctions as described earlier are formed by two hemichannels contributed by each
adjacent cell. However, hemichannels do not always form gap junction channels and have been
reported to be present in noncontacting membranes of astrocytes to allow intracellularextracellular communication (Ye et al., 2003). These functional hemichannels have been shown
to release ATP and glutamate (Orellana et al., 2011). To decrease the net transmitter released
by astrocytes during retrieval in the PL-mPFC we used the same cannula surgery, drugs,
microinfusions, and place conditioning as described above with the exception of both Gap19
(142 uM) and IRL-1620 (0.1uM) being co-infused prior to the first test trial.
Additional Experiment 3: Preventing retrieval of established CPP via blockade of astrocyte gap
junctions with IRL-1620 and blockade of astrocyte hemichannels with Gap19
To test if retrieval of a CPP could be disrupted by Gap19 + IRL-1620 after a CPP had already been
expressed we used the same cannula surgery, drugs, microinfusions, and place conditioning as
described above with the exception of both Gap19 (142 uM) and IRL-1620 (0.1uM) being coinfused prior to the second test trial after a CPP had been established in the first drug-free test
trial.
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Aim 1b: Extinction of cocaine CPP
Cannula surgery
Cannula surgeries were performed as described above, but double-barrel guide cannula
(26 gauge; Plastics One, Roanoke, VA) were implanted within IL-mPFC (AP, +2.9; ML, ±0.6; DV, 4.4 mm relative to bregma).
Drugs and microinfusions
For conditioning, cocaine HCl (National Institute on Drug Abuse) was dissolved in sterile
0.9% saline at a concentration of 10 mg/mL, and administered i.p. at a dose of 10 mg/kg. ILmPFC infusions of vehicle (0.9% saline), the non-selective gap junction blocker CBX (50 mM,
Tocris), the neuron specific gap junction blocker quinine (100 uM, Tocris), or the astrocyte
specific gap junction blocker IRL-1620 (0.1 uM, Tocris) were administered at 0.3 μl / side over a
2 minute time period. All drugs were dissolved in sterile 0.9% saline. Microinfusion injectors
were left in place for a minimum of 1 minute following microinfusions.
Place conditioning
Place conditioning and testing were conducted as described in Aim 1a.
Experimental manipulations
For extinction testing, rats was separated into one of four groups. The vehicle group
contained control animals that received vehicle (0.9% saline). Group CBX received the nonselective gap junction blocker CBX. Group IRL-1620 received the astrocyte specific gap junction
blocker IRL-1620. Group Quinine received the neuron specific gap junction blocker quinine.
Following conditioning and 10 minutes prior to the first extinction test, all groups received their
respective drug manipulation. During the CPP test, all animals had full access to all chambers for
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30 minutes to accelerate extinction learning (Otis et al., 2014). Additional drug-free daily
extinction tests followed to determine if gap-junction blockade had any persistent effect on
extinction learning. Animals continued to receive daily drug-free CPP tests until they reached
an extinction criterion of two consecutive days of no significant CPP.

Behavior data analysis
Cocaine seeking was analyzed by comparing time spent between the cocaine, saline, and
center chambers across trials and between groups using one-way ANOVAs for each individual
day of testing. If a significant effect of chamber was found, post-hoc Tukey’s Honestly Significant
Difference (HSD) tests were used to compare the amount of time spent in the cocaine-paired
versus the saline-paired chambers during the CPP trial.
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Methods: Aim 2
Aim 2 was completed using confocal microscopy to determine the effects of the gap
junction blockers used in Aim 1 on PL-mPFC astrocyte cytoplasmic calcium levels.

Tissue preparation and removal for astrocyte identification
To image astrocyte morphology in vivo, a single intraperitoneal injection of the
fluorescent dye sulforhodamine 101 (SR101; 100 mg/kg) was dissolved in saline and
administered to the animal 40 minutes prior to sacrifice. Astrocytes have been shown to
selectively take up SR101 in vivo (Nimmerjahn et al., 2004; Appaix et al., 2012; Perez-Alvarez et
al, 2013). Although the mechanism of uptake is still unknown, there is evidence showing that
metabolites such as glucose and sulforhodamine spread efficiently across astroglial networks
through gap junctions present in the astrocytic membrane (Rouach et al., 2008). Astrocyte
staining were visualized 40–60 min after injection.
For tissue removal rats were anesthetized with isoflurane, and brains were quickly
removed and put into ice-cold (0-2°C) oxygenated (95% O2 / 5% CO2) artificial cerebral spinal
fluid (aCSF) composed of the following (in mM): 124 NaCl, 2.8 KCl, 1.25 NaH2PO4, 2 MgSO4, 2
CaCl2, 26 NaHCO3, and 20 dextrose. Coronal slices 300 μm thick containing prefrontal cortex
were taken using a vibratome (Leica VT1200). Slices were then allowed recover in continuously
oxygenated warm aCSF (32°C) for approximately 30 minutes, followed by incubation in
continuously oxygenated room temperature aCSF for 0.5-8 hours when not in use.
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Loading of astrocytes with calcium indicator
To prepare the tissue for calcium visualization within astrocytes, brain slices labeled with
SR101 were loaded with the fluorescent calcium indicator Fluo-4-AM. Fluo-4-AM was used in
conjunction with SR101 for calcium imaging of astrocytes (Appaix et al., 2012; Perez-Alvarez et
al, 2013).
50 μg of Fluo-4-AM was added to 4.5 μl of fresh dimethyl sulfoxide (DMSO) and 4.5 μl of
70000 MW of Dextran (to aid in locating the Fluo-4-AM injection site) and was then vortexed
thoroughly. Next we loaded a glass pipette with dye solution and lowered it to the surface of
the slice above this field using a standard microelectrode holder. We then slowly lowered the
pipette to approximately 40 μm below the slice surface using a standard micromanipulator
(Narishige) and applied back pressure to the pipette to eject 2 nl of Fluo-4-AM per injection into
the PL-mPFC. To ensure that a large number of astrocytes take up Fluo-4-AM, we injected a
second and third Fluo-4-AM bolus short distances away, approximately 80-100 μm away from
the first injection site, and repeated bolus injections at this site. We then slowly retracted the
pipette tip from the slice by raising the pipette back to the surface of the slice, made sure that
the pipette was not clogged, and removed the pipette. We then allowed 30 min before imaging
for the astrocytes to take up the dye and for the background signal to diminish.
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Experimental manipulations
Tissue slices loaded with SR101 and Fluo-4-AM were then separated into one of eight
groups:
1. Control (no gap junction blockade treatment)
2. Treatment with 100 μM CBX for 5 min prior to scan
3. Treatment with 0.1 μM IRL-1620 for 5 min prior to scan
4. Treatment with 100 μM Quinine for 5 min prior to scan
5. Treatment with 100 μM Norepinephrine (NE) for 2 min prior to scan
6. Treatment with 100 μM CBX for 5 min then with 100 μM NE for 2 min prior to scan
7. Treatment with 0.1 μM IRL-1620 for 5 min then with 100 μM NE for 2 min prior to scan
8. Treatment with 100 μM Quinine for 5 min then with 100 μM NE for 2 min prior to scan
NE can evoke calcium-induced calcium sharing between astrocytes (Salm & McCarthy, 1990;
Duffy & MacVica, 1995). All drugs were mixed into aCSF.

Confocal microscopy, recording astrocytic calcium activity
PL-mPFC Fluo-4-AM injection sites were visualized with differential interference contrast
using a 60X water-immersion lens mounted on an Nikon C2 Scanning Confocal microscope
(Nikon Instruments). To set up the confocal microscope for imaging, we set the default values
for each laser to a high photomultiplier setting, 1x gain and 0.5% laser output power. We also
applied a 1.5x zoom for better visualization of astrocytes. Next we set the field resolution to
512 x 512 pixels. SR101-fluorescence was detected through a bandpass filter of 503-548 nm for
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the 488 nm laser. Fluo-4-AM-fluorescence was detected through a bandpass filter of 624-724
nm for the 559 nm laser (see Figure 6).
To record astrocyte calcium activity we drew boxes using the image acquisition NIS
Elements Imaging Software over regions of interest (ROIs) within the cell, in this case over
astrocyte cell bodies. We then recorded fluorescence over time from the ROI. Any increases in
fluorescence over baseline indicated increases in cytoplasmic calcium concentration (Takahashi
et al., 1999). Tissue was scanned 200 times with each scan lasting 4.5 seconds over the course
of 15 minutes. Each individual scan measured and averaged the highest and lowest intensity of
Fluo-4-AM intensity (mean intensity). We also subtracted away background fluorescence from
our ROI fluorescent value for each scan. The mean intensity value of each scan was taken for
analysis.
Analysis of astrocyte calcium activity
Since Fluo-4-AM naturally decays during exposure to the confocal laser, the mean
intensity of each scan was compared to the initial scan. To normalize the data the initial scan
mean was assigned the starting value of 100 and each subsequent scans value was calculated
relative to the initial scan’s value of 100. For example, if during the initial scan the mean
intensity was 851.36 and received the starting value of 100, the second scan with a mean
intensity of 848.85 was receive a value of 99.71. Use of these calculations allowed all the
different cells in the same treatment groups to be collectively analyzed and plotted over the
course of the 200 scans. Plotting data this way allowed a polynomial curve to be established for
each tissue slice. Next, using the Riemann sum formula (B1+B2)/2*(A2-A1) we were able to
calculate the total area under the curve to provide a measure of the total amount of calcium
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fluoresced over the entire 200 scans. Using Riemann sum formula for example, if B1 represents
scan number 1, B2 is scan number 2, A2 is mean intensity value of scan 2, and A1 is the mean
intensity value scan 1. You then continue to reapply this equation and subsequently B1 then
represents the x-axis value of scan number 2, B2 is the x-axis value of scan number 3, A2 is
mean intensity value of scan 3, and A1 is the mean intensity value scan 2. We repeated this
area under the curve equation for all 200 scans to establish a relative overall intensity value for
each scan. Finally, using ANOVA we were able to compare total areas under each curve for
each treatment group. If a significant effect was found, post-hoc Tukey’s Honestly Significant
Difference (HSD) tests will be used to identify which individual treatment group significantly
differed from another.
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Results
Aim 1
Memory retrieval of conditioned place preference
Following conditioning, rats were given 15 minute CPP trials across days to examine both
retrieval and retention of a cocaine-associated memory. We hypothesized that general gap
junction or astrocytic gap junction blockade would prevent retrieval whereas neuronal gap
junction blockade would not. PL-mPFC infusions (Figure 1) of vehicle, CBX (50 mM), IRL-1620 (.1
uM), or quinine (100 uM) were administered prior to the first trial. PL-mPFC CBX or IRL-1620
prevented CPP expression on the first and subsequent infusion-free trials whereas quinine
prolonged CPP expression trials (Figure 1). Repeated measures ANOVA revealed a significant
effect of chamber for vehicle (F2,22=30.14, p<0.05), carbenoxolone (F2,20=20.70, p<0.05), IRL1620 (F2,18=29.37, p<0.05), and quinine treatment (F2,18=23.06, p<0.05). Post hoc analyses
confirmed that vehicle, IRL-1620-treated, and quinine-treated groups expressed a CPP during
the first trial (p < 0.05), whereas the CBX-treated group did not (p > 0.05). On subsequent test
trials 2 and 3, vehicle and quinine-treated groups continued to express a CPP (p < 0.05),
whereas the CBX-treated group continued to express a CPP deficit (p > 0.05). Moreover, the IRL1620-treated group began to demonstrate a CPP deficit across trials (p > 0.05). Overall, these
data demonstrate that general and astrocyte-specific gap junction blockade prevents retrieval of
a CPP, an effect that persists even in the absence of additional treatment.
On trial 4, the vehicle, CBX-treated, and IRL-1620-treated groups expressed a CPP deficit
(p > 0.05) whereas the quinine-treated group continued to express a CPP (p < 0.05). Thus,
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neuron-specific gap junction blockade in the PL-mPFC prolongs CPP expression. Additionally,
during test trials 5 and 6, the quinine-treated group continued to express a CPP (p < 0.05),
whereas the vehicle-treated group did not, thus further demonstrating that neuron-specific gap
junction blockade in the PL-mPFC prolongs CPP expression. For the CBX-treated and IRL-1620
treated groups in test trials 5 and 6, a weak but significant CPP re-emerged (p < 0.05),
suggesting that the CPP deficit in previous trials was somewhat transient.
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Figure 1. PL-mPFC blockade of general or astrocyte-specific gap junctions prevent extinction of a
cocaine-CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 11), CBX
(n = 10), IRL-1620 (n = 9), and quinine (n = 10). White circle represents Vehicle, black circles
represent experimental groups. Right, IL-mPFC infusions (arrows) of CBX or IRL-1620 but not
quinine before the first CPP trial prevented extinction of the CPP. **p < 0.01, *p < 0.05. Error
bars indicate SEM.
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Following the observation that neuron-specific gap junction blockade with quinine in the
PL-mPFC prolonged CPP expression across days, we hypothesized that a reintroduction of
GABAergic tone would oppose this effect and promote extinction. Following conditioning, rats
were given 15 minute trials to test for CPP expression across days. As predicted, animals that
received a PL-mPFC infusion of both the neuron-specific gap junction blocker quinine (100 uM)
and the potent GABAA receptor agonist muscimol (.0001 uM) prior to the first trial showed
similar drug-seeking and extinction behavior as control animals (Figure 3). Repeated measures
ANOVA revealed a significant effect of chamber for vehicle (F2,20=34.71, p<0.05) and quinine +
muscimol groups (F2,18=29.95.06, p<0.05). Post hoc analyses confirmed that vehicle and quinine
+ muscimol-treated groups expressed a CPP during the first, second, and third trial (p < 0.05),
but not during the fourth, fifth, and sixth trial (p > 0.05). Thus, restoring GABAergic tone in the
presence of neuron-specific gap junction blockade in the PL-mPFC restores normal drug-seeking
behavior and extinction of the CPP.
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Figure 2. PL-mPFC infusion of both neuron-specific gap junction blocker quinine and
GABAA receptor agonist muscimol restores normal drug-seeking behavior and extinction of the
CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 10) and quinine +
muscimol (n = 9). White circle represents Vehicle, black circles represent experimental groups.
Right, PL-mPFC infusions (arrows) of vehicle or quinine + muscimol before the first CPP trial
resulted in similar retrieval and extinction of the CPP. ***p < 0.001, **p < 0.01, *p < 0.05. Error
bars indicate SEM.
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Gap junctions are formed by two hemichannels contributed by each adjacent cell.
However, hemichannels do not always form gap junction channels and have been reported to
be present in noncontacting membranes of astrocytes to allow intracellular-extracellular
communication (Ye et al., 2003). These functional unopposed hemichannels have been shown
to release ATP and glutamate (Orellana et al., 2011). Thus, we investigated if unopposed
hemichannels affected drug-seeking behavior either independently or in conjunction with
astrocyte-specific gap junctions. We hypothesized that animals receiving the unopposed
hemichannel blocker Gap19 would show similar retrieval blockade as the IRL-1620 animals from
the second experiment (see Figure 2) and animals receiving both Gap19 and IRL-1620 would
demonstrate a more persistent retrieval blockade than either group of animals independently
treated with Gap19 or IRL-1620.
Following conditioning, rats were given 15 minute trials to test for CPP expression across
days. Animals that received a PL-mPFC infusion of the unopposed hemichannel blocker Gap19
(142 uM) alone prior to the first trial showed weaker but longer-lasting CPP expression across
days. Animals that received a PL-mPFC infusion of both Gap19 (142 uM) and IRL-1620 (0.1uM)
showed a lack of CPP expression across days (Figure 4). Repeated measures ANOVA revealed a
significant effect of chamber for the vehicle (F2,20=34.22, p<0.05), Gap19 (F2,22=43.31, p<0.05),
and Gap19 + IRL-1620 groups (F2,22=43.31, p<0.05). Post hoc analyses confirmed that both the
vehicle and Gap19 groups expressed a CPP during the first trial (p < 0.05). The vehicle group
then continued to express a CPP during the second and third trial (p < 0.05), but not during the
fourth, fifth, and sixth trial (p > 0.05). The Gap19 group continued to show a CPP during trial
three and trial five (p < 0.05), but during trial two and trial four did not (p > 0.05). The Gap19 +
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IRL-1620 group did not express CPP on any trial, and post hoc analyses confirmed no
significance in time spent between the cocaine-paired and saline-paired chamber (p > 0.05).
Thus, blockade of either astrocyte-specific gap junctions (Figure 2) or astrocyte unopposed
hemichannels in the PL-mPFC does not prevent initial retrieval of a CPP, but impairs subsequent
CPP expression across days. Joint blockade of both astrocyte unopposed hemichannels and
astrocyte-specific gap junctions in the PL-mPFC persistently blocks CPP expression.
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Figure 3. PL-mPFC infusion of both unopposed hemichannel blocker Gap19 and astrocytespecific gap junction blocker IRL-1620 persistently disrupts retrieval of CPP. Left, Coronal
drawings showing injector tip placements for vehicle (n = 10), Gap19 (n = 11), and Gap19 + Irl1620 treated animals (n = 11). White circle represents Vehicle, black circles represent
experimental groups. Right, PL-mPFC infusions (arrows) of Gap19 + Irl-1620 before the first CPP
trial persistently disrupts retrieval of CPP whereas infusions of vehicle or Gap19 does not. **p <
0.01, *p < 0.05. Error bars indicate SEM.
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To test if retrieval of a CPP could be disrupted by Gap19 + IRL-1620 after a CPP had
already been expressed, we next examined the effect of Gap19 + IRL-1620 on retrieval by
microinfusion prior to the second trial after a CPP had already been expressed. Following
conditioning, all rats expressed a CPP for the previously cocaine-paired chamber during the first
trial. PL-mPFC microinfusions of Gap19 + IRL-1620 (n=11), but not vehicle (n=9) before the
second trial impaired expression of the CPP on that trial and all subsequent trials (Figure 5).
Repeated measures ANOVA revealed an effect of chamber for both groups during the first trial
(vehicle F2,22=24.07, p<0.05; Gap19 + IRL-1620, F2,18=19.27, p<0.05), and post hoc analyses
confirmed that both groups spent significantly more time in the cocaine-paired chamber than
the saline-paired chamber (p<0.05). Following microinfusion of Gap19 + IRL-1620 or vehicle
prior to the second trial, only the vehicle-treated rats spent significantly more time in the
previously cocaine-paired chamber (effect of chamber: F2,22=16.44, p<0.05, post hoc p<0.05),
whereas Gap19 + IRL-1620-treated rats spent an equivalent amount of time in all chambers
(F2,18=4.11, p>0.05). On subsequent infusion-free trials, vehicle-treated rats continued to spend
significantly more time in the cocaine-paired chamber overall (effect of chamber:
F2,22=7.61, p<0.05, post hoc p<0.05), whereas Gap19 + IRL-1620-treated rats spent an equivalent
amount of time in all chambers (F2,18=1.18, p>0.05). Therefore, Gap19 + IRL-1620 infusions into
PL-mPFC disrupted the retrieval of a previously expressed CPP.
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Figure 4. PL-mPFC infusion of both unopposed hemichannel blocker Gap19 and astrocytespecific gap junction blocker IRL-1620 disrupts retrieval of an established CPP. Left, Coronal
drawings showing injector tip placements for vehicle (n = 9), Gap19 + IRL-1620 treated animals
(n = 11). White circle represents Vehicle, black circles represent experimental groups. Right, all
rats expressed a CPP for the previously cocaine-paired chamber over the previously salinepaired chamber during the first test trial. PL-mPFC infusions (arrows) of Gap19 + IRL-1620 but
not vehicle before the second CPP trial prevented rats from expressing a CPP during the second
trial and subsequent trials. ***p < 0.001, **p < 0.01, *p < 0.05. Error bars indicate SEM.
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Extinction of conditioned place preference
Following conditioning, rats were given longer 30 minute CPP trials that has been shown
to promote extinction learning (Otis et al., 2014). We hypothesized that general gap junction or
astrocytic gap junction blockade would prevent extinction whereas neuronal gap junction
blockade would not. IL-mPFC infusions (Figure 1) of vehicle, CBX (50 mM), IRL-1620 (.1 uM), or
quinine (100 uM) were administered prior to the first trial. IL-mPFC carbenoxolone or IRL-1620
impaired extinction across days (Figure 5). Repeated measures ANOVA revealed a significant
effect of chamber for the vehicle (F2,22=18.45, p<0.05), carbenoxolone (F2,20=14.635, p<0.05),
IRL-1620 (F2,20=11.78, p<0.05), and quinine groups (F2,20=17.39, p<0.05). Post hoc analyses
confirmed that all groups expressed a CPP during the first trial (p < 0.05). However, only
carbenoxolone-treated and IRL-1620-treated rats expressed a CPP during subsequent trials (i.e.,
trials 2-4; p < 0.05), whereas vehicle-treated and quinine-treated rats did not (p > 0.05). Thus,
IL-mPFC general or astrocyte specific gap junction blockade impaired extinction of the CPP.
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Figure 5. IL-mPFC blockade of general or astrocyte-specific gap junctions prevent extinction of a
cocaine-CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 11), CBX
(n = 10), IRL-1620 (n = 9), and quinine (n = 10). White circle represents Vehicle, black circles
represent experimental groups. Right, IL-mPFC infusions (arrows) of CBX or IRL-1620 but not
quinine before the first CPP trial prevented extinction of the CPP. **p < 0.01, *p < 0.05. Error
bars indicate SEM.
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Aim 2
PL-mPFC astrocytic calcium levels following general, neuronal, or astrocytic gap junction
communication blockade was next investigated. Following tissue removal and preparation of
SR-101 and Fluo-4-AM (Figure 6), PL-mPFC tissue was treated with one of the following
treatments:
1. Control (no gap junction blockade treatment) - 6 animals, 7 slices, 26 cells.
2. Treatment with 100 μM for 5 min prior to scan - 6 animals, 6 slices, 21 cells.
3. Treatment with 0.1 μM IRL-1620 for 5 min prior to scan - 6 animals, 6 slices, 22 cells.
4. Treatment with 100 μM Quinine for 5 min prior to scan - 6 animals, 6 slices, 20 cells.

NE has previously been shown to evoke calcium-induced calcium sharing between
astrocytes (Salm & McCarthy, 1990; Duffy & MacVica, 1995). So we also tested to see if various
gap junction blockade treatments would prevent NE evoked calcium-induced calcium rise in
astrocytes.
5. Treatment with 100 μM NE for 2 min prior to scan - 6 animals, 6 slices, 25 cells.
6. Treatment with 100 μM CBX for 5 min then with 100 μM NE for 2 min prior to scan - 6 animals,

6 slices, 18 cells.
7. Treatment with 0.1 μM IRL-1620 for 5 min then with 100 μM NE for 2 min prior to scan - 6

animals, 6 slices, 18 cells.
8. Treatment with 100 μM Quinine for 5 min then with 100 μM NE for 2 min prior to scan - 6

animals, 6 slices, 16 cells.
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Following tissue removal, slices containing the PL-mPFC were prepared as described
above. We hypothesized neuronal gap junction blockade or NE treatment would increase PLmPFC basal astrocyte cytoplasmic calcium levels whereas general gap junction or astrocytic gap
junction blockade would not. Additionally, we hypothesized that tissue receiving NE treatment
after neuronal gap junction blockade would increase PL-mPFC astrocyte cytoplasmic calcium
levels whereas NE treatment after general gap junction blockade or astrocytic gap junction
blockade would not. We observed that bath application of NE (Figure 7) or quinine (Figure 10)
increased PL-mPFC basal astrocyte cytoplasmic calcium levels whereas bath application of CBX
(Figure 8), or IRL-1620 (Figure 9) had no effect on PL-mPFC basal astrocyte cytoplasmic calcium
levels. Additionally, CBX (Figure 11) or IRL-1620 (Figure 12) treatment prevented NE from
increasing PL-mPFC astrocyte cytoplasmic calcium levels, whereas quinine (Figure 13) did not.
ANOVA revealed an overall effect of group (F7,164=3.46, p<0.05) and post hoc analyses confirmed
that the area under the curve (AUC) for the control group was significantly lower than the NE
group AUC (ps<0.05), the quinine group AUC (ps<0.05), and the quinine + NE group AUC
(ps<0.05). Thus, NE or neuronal gap junction blockade via quinine increases cytoplasmic
calcium levels in astrocytes. Additionally, the IRL 1620 + NE group AUC was significantly lower
than the NE group AUC (ps<0.05). Thus, astrocyte-specific gap junction blockade via IRL-1620
prevented the NE-induced increase of calcium levels. Overall, NE or neuronal gap junction
blockade increases basal cytoplasmic calcium levels in PL-mPFC astrocytes and blocking
astrocyte gap junctions can prevent NE-induced calcium level increases.
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Figure 6. Imaging of PL-mPFC astrocytes using confocal microscopy.
Top left, At 40x magnification, astrocyte cell bodies were identified in red using SR-101 staining.
Top right, Fluo-4-AM staining in green identified calcium.
Bottom left, Merged images show that Fluo-4-AM staining of calcium is co-localized within
astrocyte cell bodies.
Bottom right, Example ROI collection.
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Discussion
These studies aimed (1) to determine whether gap junction communication is a
mechanism for memory retrieval and extinction of a cocaine CPP and (2) to evaluate PL-mPFC
astrocytic calcium levels following general, neuronal, or astrocytic gap junction communication
blockade.
Results revealed that, within the PL-mPFC, general and astrocyte-specific gap junction
blockade prevent retrieval of a CPP whereas neuronal-specific gap junction blockade prolonged
drug-seeking behavior. Additional behavioral experiments within the PL-mPFC revealed that
restoring GABAergic tone in conjunction with blockade of neuronal-specific gap junctions
restored normal memory retrieval and extinction of a CPP. Furthermore, blocking unopposed
astrocyte hemichannels in conjunction with astrocyte-specific gap junctions prevented initial
and subsequent memory retrieval of a CPP, whereas blockade of just astrocyte gap junction or
just unopposed astrocyte hemichannels did not. Additionally, blocking PL-mPFC unopposed
astrocyte hemichannels in conjunction with astrocyte-specific gap junctions prevented memory
retrieval of a CPP after a CPP had been established. Finally within aim 1, blockade of IL-mPFC
general and astrocyte-specific, gap junctions prevented extinction of a CPP.
In Aim 2, I examined the effects of the various gap junction blockers on calcium
dynamics in PL-mPFC. Neuronal-specific gap junction blockade increased cytoplasmic calcium
levels in astrocytes, whereas astrocyte-specific gap junction blockade did not. Furthermore, NE
exposure induced an increase in cytoplasmic calcium levels in astrocytes, but pre-application of
an astrocyte-specific gap junction blocker prevented the NE-induced rise. In contrast, neuronspecific gap junction blockade did not prevent the NE-induced rise in calcium levels in
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astrocytes. Taken together, astrocyte and neuronal gap junctions play differential roles in
memory retrieval and extinction of a CPP and have opposing effects on basal and NE-induced
calcium levels in PL-mPFC astrocytes.

Aim 1
Data revealed that blocking PL-mPFC astrocyte specific gap junctions and unopposed
hemichannels prevented memory retrieval of a CPP both during the initial and subsequent test
trials. Furthermore, data revealed that blocking PL-mPFC astrocyte specific gap junctions and
unopposed hemichannels prevented memory retrieval of a CPP after a CPP had been
established. Previous data has shown that astrocyte gap junction communication influences
neural activity (Parri et al., 2001). Additionally, blocking unopposed hemichannels in astrocytes
decreases the release of glutamate and ATP (Ye et al., 2003) and decreases CA1 pyramidal
neurons EPSC amplitudes in mice (Chever et al., 2014). Our data further revealed that blockade
of astrocyte gap junctions alone or unopposed astrocyte hemichannels alone did not prevent
initial memory retrieval, but did prevent subsequent retrieval of a CPP. Additionally, a return of
a CPP was observed on test trial 6 for the astrocyte gap junction blockade animals even though
during test trials 2-5, a CPP was not expressed. Overall, our data support that astrocytes can
communicate to other astrocytes and neurons to mediate cocaine-associated memory retrieval
in PL-MFC. In fact, these data are the first to demonstrate that blocking both PL-mPFC astrocyte
gap junction communication and unopposed astrocyte hemichannels can persistently prevent
memory retrieval of a drug-associated memory. Further investigation is necessary to determine
the specific transmitters being released by astrocytes to neurons within the PL-mPFC to allow
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memory retrieval to occur and what short and long term plasticity events can occur to cause a
return of CPP expression following gap junction blockade.
PL-mPFC neuron-specific gap junction blockade prolonged drug-seeking behavior as
compared to vehicle control. Restoring PL-mPFC GABAergic tone in conjunction with blocking
neuron-specific gap junctions restored animals to normal drug-seeking behavior comparable to
controls. Previous work has shown that GABAergic inhibitory interneurons selectively express
Cx36 (Belluardo et al., 2000). The application of quinine selectively blocks Cx36 (Cruikshank et
al., 2004) and has been shown to increase spike frequency in CA3 recordings of guinea pig tissue
slices (Yoshida et al., 1986). The authors proposed that quinine’s mechanism of action on neural
activity was through blockade of an after-hyperpolarizing potassium channel (Yoshida et al.,
1986). Overall, our data support the conclusion that blocking Cx36 in inhibitory interneurons
leads to a decrease of inhibitory signal in local circuitry and a net increase in activity within a
structural region of the brain.
PL-mPFC non-specific gap junction blockade prevented memory retrieval of a CPP on
test trials 1-4, but caused a return of preference on test trials 5-6. These data may be
anomalous, or they may reflect the combined effects of astrocyte and neuron specific gap
junction blockade. The initial trials appear similar to those from the IRL-1620 group, whereas
later trials appear similar to those from the quinine group during which the preference returns
even after the control animals have extinguished their drug-seeking behavior. CBX has been
one of the most widely used non-selective gap junction blockers (Moradi et al., 2013; Chepkova
et al., 2008; Schoenfeld et al., 2014) and has been shown to reduce neural activity (Tover et al.,
2009) impair LTP (Chepkova et al., 2008), and decrease diffusion of gap junction channel54

permeable dye between astrocytes (Sun et al., 2012). No other data are currently available
showing the long-lasting effect of CBX on neuron or astrocyte activity, but CBX can washout
during electrophysiological recordings after 30 min (Alvarex-Maubecin et al., 2000).
Interestingly, it has been observed that CBX blocks unopposed astrocyte hemichannels in
addition to being a non-selective gap junction blocker (Ye et al., 2003). Thus, further study of
CBX’s dynamics will be needed to determine the extent of effects on both neurons and
astrocytes.
Results revealed that general or astrocyte-specific gap junction blockade in IL-mPFC
prevented extinction learning whereas neuron-specific gap junction blockade accelerated
extinction learning. These results are similar to those found in the PL-mPFC behavioral studies,
where general and astrocyte-specific gap junction blockade prevented the function of the PLmPFC whereas neuron specific gap junction blockade accelerated and had the opposite effect
on the PL-mPFC. Taken together, drug-associated retrieval and extinction memories can be
impaired or strengthened by blocking specific gap junction activities, with astrocyte and
neuronal gap junctions serving opposing roles in regions of the brain involved in memory
retrieval and extinction of drug-seeking behavior.

Aim 2
Our data revealed that astrocyte gap junction blockade prevented a NE-induced increase
in cytoplasmic calcium levels in astrocytes. NE can evoke a calcium increase within astrocytes
(Salm & McCarthy, 1990). In the absence of provoking conditions, spontaneous calcium activity
in individual astrocytes does not spread among astrocytes as an intercellular calcium wave (Nett
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et al.2002). In baseline conditions, the magnitude of correlated activity in nearby and distant
astrocytes is quite similar (Hirase et al., 2004).
Gap junction blockade does not render an astrocyte unable to release transmitter, which
could explain why PL-mPFC IRL-1620 treated animals in aim 1 showed a significant preference
on day 1 of testing. Calcium and cAMP are active in SNARE-dependent merger of vesicles
(Vardjan & Zorec, 2015) and calcium increases in a single astrocyte can lead to the release of
transmitters like glutamate and ATP (Parpura et al., 1994). Thus, for a single astrocyte to release
its own transmitter, gap junction communication is not always necessary. However, when gap
junctions between astrocytes are open, calcium waves between astrocytes can lead to a much
more unified release of transmitter from an ensemble of astrocytes that can then communicate
to other nearby astrocytes and neurons. For example, glutamate can induce astrocytic calcium
waves (Innocenti et al., 2000) in addition to causing a calcium rise inside a single astrocyte.
Once calcium waves begin, they can exhibit oscillatory behavior that can persist for periods of
5–30 min at variable frequencies (10–110 mHz). A direct correlation between glutamate
concentration and the frequency of oscillations has also been observed. At low concentrations
(below 1 μM), intracellular calcium transients are asynchronous and localized. In contrast, at
higher concentrations of glutamate (10–100 μM), calcium waves propagate over longer
distances (Cornell-Bell et al., 1990). Additionally, rhythmic oscillatory calcium waves can release
trasnmitters in a unified manner that affect the local field potentials of neurons (Tewari &
Parpura, 2015). IRL-1620 decreases calcium wave propogation by roughly 80-90 percent in
hippocampal and striatal astrocytes (Blomstrand et al., 1999). Taken together our data suggests
that blocking astrocyte gap junction communication with IRL-1620 prevents NE-induced
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oscillatory actions of calcium waves (Paukert et al., 2014; Salm & McCarthy, 1990).
Because the astrocytic release of transmitters is slower than neuron communication,
some theorize that the astrocytic system regulates homeostatic processes. Astrocytic
transmission thus models the endocrine system in that it is slower than the neuronal
transmission but more widespread. For example, when astrocytes connected to arterioles elicit
calcium waves, there is an increase in the release of vasoactive compounds (Bezzi et al.
1998). This work supports the idea that astrocytes function to regulate local circulation
according to the metabolic needs of neurons.
PL-mPFC tissue exposed to the neuron-specific gap junction blocker quinine significantly
increased cystolic calcium in astrocytes. Our data from aim 1 revealed that increasing
GABAergic tone within the PL-mPFC counteracts quinine’s effect of prolonging drug-seeking
behavior. These data offer evidence that a decrease in GABAergic tone on pyramidal neurons
cause an increase in neuronal transmitter reléase that can trigger astrocytic calcium waves.
Furthermore, co-localizing Cx36 mRNA with parvalbumin, a GABAergic interneuron marker,
shows that GABAergic inhibitory interneurons express Cx36 (Belluardo et al., 2000) and quinine
specifically blocks channel conductance of Cx36 (Cruikshank et al., 2004). Other data suggest
that quinine may have another mechanism to increase neuronal excitability. Quinine increases
the excitability of CA3 pyramidal neurons, possibly through blockade of an AHP – K+ channel
(Yoshida et al., 1986). This proposed mechanism is activated by protein kinase A (PKA; Liu et al.
1999) and PKA is able to regulate AMPA receptor recruitment to the plasma membrane (Gomes
et al., 2004) to further increase neuronal excitability.
PL-mPFC tissue exposed to the general gap junction blocker CBX did not significantly
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decrease cystolic calcium in astrocytes, as compared to tissue treated with NE. We originally
hypothesized that CBX would prevent a NE-induced increase in astrocyte cytoplasmic calcium
similar to the IRL-1620 treated tissue based on previous findings that CBX reduces neural
activity (Tover et al., 2009) impairs LTP (Chepkova et al., 2008), and decreases diffusion
of gap junction channel-permeable dye between astrocytes (Sun et al., 2012). Our data offers a
possible explanation as to why CBX was unable to significantly decrease the cytoplasmic calcium
levels in astrocytes. CBX blocks both astrocyte and neuron gap junctions, and our data reveal
that quinine is able to significantly increase the cytoplasmic calcium levels in astrocytes
compared to baseline/control readings. A future experiment of applying both IRL-1620 and
quinine could clarify if quinine is able to increase the cytoplasmic calcium levels in astrocytes
while astrocyte gap junctions are closed.
Another intriguing aspect of our data is that the animals in aim 1 who received CBX
microinfusions into the PL-mPFC showed a retrieval deficit that was initially very prevalent, but
turned out to not persist. Since CBX can block both gap junctions and unopposed hemichannels
in astrocytes, a possible explanation as to why CBX treated animals showed a strong initial
retrieval deficit is the CBX treated animals were under similar conditions as the PL-mPFC IRL1920 + Gap19 group. However, since neuron-specific gap junctions are blocked as well with
CBX, this could explain why the PL-mPFC CBX animals in later trials displayed CPP after controls
had extinguished, similar to the PL-mPFC quinine-treated animals. Future experiments
exploring CBXs long term effects on astrocytes and neurons would help clarify the length of time
CBX is active and what plasticity triggering events follow.
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Future Directions
Gap junctions play a role in learning and memory, emotions and reward-related
behavior, and even psychiatric and behavioral disorders, but the mechanisms are poorly
understood. However, investigation of the behavioral impact of gap junctions has revealed that
pharmacological blockade of gap junctions can impair the acquisition and expression of cued
fear (Bissiere et al., 2011), bilateral hippocampus blockade of gap junctions with CBX can impair
rats performance on a water maze (Hosseinzadeh et al., 2005), and post-acquisition infusions of
the non-selective gap junction blocker 18-alpha-glycyrrhetinic acid can impair retention
performance in a one-trial discrimination avoidance task in chicks (Verwey and Edwards, 2010).
I have demonstrated that within the cocaine-associated memory paradigm of a
conditioned place preference that general or astrocyte gap junction blockade decreases drugseeking behavior whereas neuronal gap junction blockade prolongs drug-seeking behavior. Gap
junction blockade has been theorized to reduce the level of neuronal excitability (Kokarovtseva
et al., 2013), however whether this is due to astrocytic and neuronal gap junction closure or just
one specific type remains unclear. Whole cell patch clamp electrophysiology using the either
IRL-1620 or quinine could determine which specific gap junction type mediates the effects
observed with a general gap junction blocker such as CBX. Based on my results, I would predict
that the application of IRL-1620 would decrease neuronal excitability whereas quinine would
increase neuronal excitability.
Evidence described here indicates that blocking astrocyte gap junctions prevents an
increase in calcium levels within astrocytes. Because astrocytes release transmitters in a
calcium-dependent manner, it would be interesting to see what short and long-term plasticity
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events can occur within both astrocytes and neurons following prolonged gap junction
blockade. The blockade of glutamate exchange between astrocytes and neurons increases and
decreases vesicular glutamate release in pre-synaptic neurons. It also promotes AMPA receptor
insertion in post-synaptic neurons during withdrawal (Kalivas 2009) but it not known if this is
dependent on gap junction communication of astrocytes. Electrode recordings of extracellular
levels of glutamate (Hu et al., 1994) and protein analysis of AMPA receptors (Brown et al., 2002)
at various time points following IRL-1620 application could determine if astrocyte gap junctions
influence neuronal plasticity. From the results gathered here, I predict that blocking astrocyte
gap junctions will decrease extracellular glutamate levels and decrease AMPA receptor levels in
neurons.

Clinical Relevance
Previous work has demonstrated that gap junction dysfunction in the prefrontal cortex
can induce depressive-like behaviors in rats (Sun et al., 2012). Following chronic unpredictable
stress, animals exhibited significant decreases in diffusion of gap junction channel-permeable
dye and expression of Cx43. However, the cellular and behavioral alterations induced by the
chronic unpredictable stress were reversed and/or blocked by treatment with the
antidepressants fluoxetine and duloxetine. Beyond fluoxetine’s SSRI effect on depression,
fluoxetine also has an anti-depressant effect by increasing expression of the vesicular glutamate
transporter-1 (VGLUT1) in the PFC (Farley et al., 2012; Chen et al., 2014). However, it is not
known if VGLUT1 expression is elevated in neurons and/or astrocytes. Therapeutically, targeting
astrocytes or neurons can create a “chicken or egg” effect concerning which cell influences the
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other, but further investigation could reveal a greater holistic view of antidepressants on both
healthy gap junction and synaptic communication. Lastly, previous work from our lab has shown
that blocking β-adrenergic receptors with specific and non-specific β-adrenergic blockers like
propranolol or betaxolol can prevent retrieval of a CPP (Otis and Mueller, 2011; Otis et al., 2013,
2014; Fitzgerald et al., 2016). It would be interesting to investigate how β-adrenergic blockade
also influences the communication between astrocyte and neuronal networks because
astrocytes express a variety of Gq-coupled alpha adrenergic receptors (Cahoy et al., 2008), and
exogenous norepinephrine triggers a rise in calcium in astrocytes (Salm and McCarthy, 1990)
that can lead to SNARE-dependent merger of a vesicle membrane with the plasma membrane
(Vardjan & Zorec, 2015).

Conclusion
These studies aimed (1) to determine whether gap junction communication is a
mechanism for memory retrieval and extinction of a cocaine CPP and (2) to evaluate PL-mPFC
astrocytic calcium levels following general, neuronal, or astrocytic gap junction communication
blockade. Overall this dissertation provides evidence that both gap junction communication and
the communication between astrocytes and neurons are both actively involved with memory.
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